Vanderhyden Lab

Barbara Vanderhyden profile picture

Contact Information

Barbara Vanderhyden, PhD
613-737-7700 ext. 70330

Ottawa Hospital Research Institute
Centre for Cancer Therapeutics
501 Smyth Road
Box 926
Ottawa, ON K1H 8L6

ORCID logo


Tweaking the ovary’s immune system may help prevent ovarian cancer
October 5, 2022 - The diabetes drug metformin prevents fibrosis in the ovaries by adjusting the organ’s immune cells, according to a study in mice published in Science Advances.
Ottawa researchers recognized with international awards for reproductive biology and health
April 29, 2022 - Ottawa’s reproductive biology researchers took the lead in international recognition this year, receiving three of 12 prestigious awards from the Society for the Study of Reproduction.
Harnessing tumour diversity could improve cancer treatment
January 27, 2022 - The molecular landscape of every tumour is diverse and unique, even within the same type of cancer, according to a study published in Science Advances.
50 ways to repair an ovary? Study suggests multiple pathways can create stem-like ovarian cells
August 17, 2021 - Approximately every 28 days, hundreds of cells die and disintegrate on the ovary’s surface as an egg breaks through and begins its journey. Ovaries have become masters at repairing this damage, but exactly how they do this remains a mystery.
The Ottawa Hospital awarded six CIHR grants worth $2.6 million
September 7, 2020 - Could a common diabetes drug help prevent ovarian cancer? Can a tailored screening program help prevent eye disease in immigrants? Is sepsis different in females versus males, and if so, can this help us develop better treatments? These are just ...
Virus and targeted drug synergize to fight cancer in mice
August 26, 2020 - While some cancer cells can be killed quickly by a single drug, the reality for patients is that multiple therapies are often required, especially if resistance develops. A new study led by Dr. Jean-Simon Diallo reveals for the first time that ...
Researchers and research staff honoured for outstanding work in cancer clinical trials, emergency medicine, cell sorting and tissue collection
April 29, 2020 - A number of outstanding researchers and research teams have been honoured through The Ottawa Hospital’s Excellence Awards program for 2020. They include the Rethinking Clinical Trials (REaCT) program, Senior Clinical Research Associate in ...
Dr. Barbara Vanderhyden wins uOttawa Award for Excellence in Research
March 4, 2020 - Distinguished Professor Barbara Vanderhyden has won the highly-coveted University of Ottawa Award for Excellence in Research in the Sciences stream for 2019-2020 academic year.
Margaret's Gift
February 20, 2020 - Ovarian cancer claimed Margaret Craig’s life. Now her generous gift is opening new doors to preventing the disease. Margaret knew research would ultimately provide the solution to ovarian cancer. Her donation through her will is opening new doors ...
“Wild idea” opens possible new frontier for preventing ovarian cancer
October 9, 2019 - A laboratory study published in Clinical Cancer Research offers a new hypothesis about how ovarian cancer forms and suggests how it might be prevented. The study is the first to show that the natural stiffening of the ovaries called fibrosis ...
Dr. Barbara Vanderhyden receives international award for mentoring the scientists of tomorrow
April 12, 2019 - Dr. Barbara Vanderhyden received the 2019 Trainee Mentoring Award from the Society for the Study of Reproduction for her profound impact on the next generation of reproductive biology researchers.
Researchers get $788,000 boost from NSERC
November 21, 2018 - Four scientists from The Ottawa Hospital, affiliated with the University of Ottawa, were successful in the recent discovery grant competition from the Natural Sciences and Engineering Research Council of Canada (NSERC). Dr. Barbara Vanderhyden ...
Estrogen and ovarian cancer: study provides first molecular link
July 11, 2018 - Estrogen therapy can relieve symptoms of menopause in some women, but it also slightly increases the risk of ovarian cancer. New research from Dr. Barbara Vanderhyden's team provides the first possible molecular explanation for this link. Using ...
The Ottawa Hospital awarded $12.7M for research, double the national CIHR success rate
January 30, 2018 - Sixteen research groups at The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded $12.7 million in the most recent project grant competition from the Canadian Institutes of Health Research (CIHR). This represents a success r
Tender Loving Research working to cure ovarian cancer
September 2, 2015 - The latest edition of our Tender Loving Research blog features Dr. Barbara Vanderhyden explaining her motivation to find better ways to detect and treat ovarian cancer. Dr. Vanderhyden notes that ovarian cancer research is a pressing need since ...
Ovarian cancer researcher recognized for excellence in education
July 15, 2015 - Dr. Barbara Vanderhyden has received the Excellence in Education Prize for 2014-2015 from the University of Ottawa. The prize recognizes professors for outstanding teaching and a solid research program. Decisions are based on student evaluations, cre